J&J and Bavarian Nordic start clinical tests of Ebola vaccine

LONDON, Jan 6 (Reuters) - U.S. drugmaker Johnson & Johnson said on Tuesday it had started clinical trials of its experimental Ebola vaccine, which uses a booster developed by Denmark's Bavarian Nordic.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.